Further consequences of changes in the expression level of NFkB in the granulocytes of COVID-19 patients were changes in the expression of pro-inflammatory and anti-inflammatory interleukins; that is, in the granulocytes of patients who died from COVID-19, compared to COVID-19 survivors, there was an increase in the levels of IL-2 and IL-6 (proinflammatory interleukins) and a decrease in the level of the anti-inflammatory cytokine (IL-10) (Figure 4 and Table 1). Here, NFKB1 is linked to COVID-19.